摘要
目的:探讨糖皮质激素在重症支原体肺炎治疗中的使用价值。方法:对符合重症支原体肺炎66例患儿随机分为激素治疗组,对照组,治疗组予以甲基强的松龙4mg/kg.d,每组均常规使用阿奇霉素,观察各组临床表现,实验室检查以及后遗症发生率。结果:治疗组患儿临床症状体征消失明显早于对照组(P<0.05),后遗症发生率亦低于对照组组(P<0.05)。结论:糖皮质激素治疗重症支原体肺炎的临床疗效肯定,甲基强的松龙可在一定程度上减少后遗症的发生。
Objective：To investigate the value of glucocorticoid in the treatment of severe mycoplasma pneumonia. Methods：in line with the 66 cases of severe mycoplasma pneumonia in children with hormone therapy were randomly divided into control group,treatment group methylprednisolone be 2 - 4mg/kg.d,both the conventional use of each of azithromycin,to observe the clinical manifestations, laboratory examinations, as well as the incidence of sequelae.Results：Children with obvious clinical signs and symptoms disappear earlier than in the control group （P〈0.05）,incidence of sequelae was lower than the control group group （P〈0.05）.Conclusions： Glucocorticoid is clinical effient in the treatment of severe mycoplasma pneumonia and methylprednisolone can reduce the occurrence of sequelae,to some extent.
出处
《求医问药（下半月刊）》
2011年第9期273-274,共2页
Seek Medical and Ask The Medicine
关键词
肺炎支原体
重症肺炎
糖皮质激素
后遗症
Mycoplasma pneumoniae pneumonia with severe after-effects of glucocorticoid
